Evidence map›Paper›PMID 34884693›Full record

ReviewInternational journal of molecular sciences2021

Recent Advances in Biological Activity, New Formulations and Prodrugs of Ferulic Acid.

Monika Stompor-Gorący, Maciej Machaczka

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Exploring the potential of cinnamic acid analogues in alzheimer's disease.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Effect of Drying Methods on Bioactivity ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Green Biocatalysis of Xylitol Monoferulate:Biotech (Basel (Switzerland)) · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Monika Stompor-GorącyDepartment of Human Pathophysiology, Institute of Medical Sciences, University of Rzeszow, Kopisto 2a, 35-959 Rzeszów, Poland.ORCID 0000-0001-5618-8899
Maciej MachaczkaDepartment of Human Pathophysiology, Institute of Medical Sciences, University of Rzeszow, Kopisto 2a, 35-959 Rzeszów, Poland.ORCID 0000-0001-7711-4127
Karolinska Institutet · SEUniversity of Rzeszów · PL

Funding

National Science Centre NCN Poland 2020/39/D/NZ9/02023Polish Ministry of Education and Science STYP/15/0763/E-546/2020
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCoumaric AcidsDrug Delivery SystemsFree Radical ScavengersHumansProdrugsCoumaric Acidsferulic acidFree Radical ScavengersProdrugsantioxidantsencapsulationferulic acidnanostructuresneuroprotective action

Identifiers

PMID34884693
PMCPMC8657461
OpenAlexW3215247179

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.